Digital PCR Market to Exhibit 17.2% CAGR and Reach USD 799.1 Million by 2026; Rise Remarkably on Account of Increasing Prevalence of Genetic Disorder…

November 02, 2020 06:12 ET | Source: Fortune Business Insights

Pune, Nov. 02, 2020 (GLOBE NEWSWIRE) -- The global digital PCR market size is forecast to reach USD 799.1 million by 2026, attributed to the increasing prevalence of infectious diseases and genetic disorders worldwide. Digital PCR is the biotechnological advancement of conventional PCR and provides a reproducible and sensitive method of measuring the amount of RNA or DNA in a sample. According to this report, the market value was USD 224.9 million in 2018 and is likely to exhibit a CAGR of 17.2% within the forecast period of 2019 to 2026. As per geographical segmentation, North America earned the largest digital polymerase chain reaction market share with a revenue of USD 96.5 million earned in 2018. This is owing to the high prevalence and diagnosis rate of infectious disease and the availability of better healthcare facilities in the region.

Significant Industry Developments of the Digital PCR Market Include:

January 2019 A new series of digital PCR platform was launched by QIAGEN. This platform is based on the combined assay development expert technology of Qiagen and FORMULATRIX.

October 2019 dd-Check STEC Solution was launched by Bio-Rad Laboratories, Inc. for the detection of virulence genes from Shiga toxin-producing Escherichia coli (STEC).

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/digital-pcr-market-102014

Rise in Prevalence of Genetic Disorders to Aid in Expansion of Market

The increasing prevalence of infectious and genetic diseases is a major digital polymerase chain reaction market growth driver. In addition to this, the advancement in medical technology and introduction of innovative devices for therapeutic purposes will also aid in expansion of the market in the coming years. These innovative devices include crystal dPCR, beam dPCR chip-based digital PCR, and droplet digital PCR.

On the other side, high cost of digital polymerase chain reaction installation may pose a major challenge to the market growth. This, coupled with the lack of awareness about the availability of treatment options, especially in developing and under-developed nations, may hamper the overall market in the coming years.

Nevertheless, the gradual shift towards chip-based dPCR from droplet dPCR by healthcare providers is expected to boost the market in the coming years.

Click here to get the short-term and long-term impact of COVID-19 on this market. Please visit: https://www.fortunebusinessinsights.com/digital-pcr-market-102014

Increasing Prevalence of Genetic Disorders to help Asia Pacific Register Faster CAGR by 2026

As per geographical segmentation, North America earned the largest digital polymerase chain reaction market share with a revenue of USD 96.5 million earned in 2018. This is owing to the high prevalence and diagnosis rate of infectious disease and the availability of better healthcare facilities in the region.

In addition, there is high awareness among people about the availability of advanced dPCR devices as treatment options in the developed nations of the region. Furthermore, the increasing number of various cancer cases and metabolic diseases are also boosting the regional market.

Quick Buy - Digital PCR Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/102014

Bio-Rad, Sysmex Inostics, and Thermo Fisher to Hold Dominant Shares with Diverse Portfolio

The global digital PCR market is consolidated in nature owing to the presence of many players. Companies such as Thermo Fisher Scientific Inc., Sysmex Inostics, and Bio-Rad Laboratories, Inc., are holding majority shares in the market on account of their diverse portfolio of chip-based digital PCR and droplet digital PCR and continuous launch of innovative technologies by these companies at large.

Other players operating in this market are emphasizing on mergers and acquisitions, contracts and agreements, or other collaborative methods to attract high digital PCR market revenue and attain a significant position in the market in the coming years.

List of Manufacturers in the Digital PCR Market include:

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/digital-pcr-market-102014

Global Digital PCR Market Segmentation:

By Type

Droplet Digital PCR

Chip-based Digital PCR

Others

By Product

Instruments

Reagents & Consumables

By Indication

Infectious Diseases

Oncology

Genetic Disorders

Others

By End User

Hospitals & Clinics

Pharmaceutical & Biotechnology Industries

Diagnostic Centers

Academic & Research Organization

By Geography

North America (the U.S. and Canada)

Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)

Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)

Latin America (Brazil, Mexico, and the Rest of Latin America)

Middle East & Africa (South Africa, GCC and the Rest of Middle East & Africa)

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/digital-pcr-market-102014

SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:

Have a Look at Related Reports:

In-vitro Diagnostics (IVD) Market Share & Industry Analysis, By Product Type (Instruments, Reagents & Consumables), By Technique (Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Point of Care, Hematology and Others), By Application (Infectious Diseases, Cardiology, Oncology, Gastroenterology, Others), By End User (Clinical Laboratories, Hospitals, Physicians Offices, Others) and Regional Forecast, 2019 2026

Hepatitis C Drug Market Share & Industry Analysis, By Product (NS5A Inhibitor (Protease Inhibitors), Fixed-dose Combination, Others), By Disease Type (Acute Hepatitis C, Chronic Hepatitis C), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026

Schizophrenia Drugs Market Share & Industry Analysis, By Therapeutic Class (Second Generation, Third Generation, Others), By Treatment (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and Regional Forecast, 2019-2026

Point of Care (POC) Diagnostics Market Share and Global Trend By Product (Blood Glucose Monitoring, Infectious Diseases, Cardiometabolic Diseases, Pregnancy and Fertility Testing Products, Hematology Testing Products, Others), By End User (Hospitals Bedside, Physicians Office Lab, Urgent Care & Retail Clinics, Home and Self Testing) and Geography Forecast till 2026

Psoriatic Arthritis Treatment Market Share and Global Trend By Drug Class (Non-steroidal Anti-inflammatory Drugs (NSAIDS), Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs), Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs), Others), By Route of Administration (Oral, Parenteral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online pharmacies) and Geography Forecast till 2026

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India.

Phone: US :+1 424 253 0390 UK : +44 2071 939123 APAC : +91 744 740 1245 Email: sales@fortunebusinessinsights.com Fortune Business Insights LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/digital-pcr-market-9708

Follow this link:
Digital PCR Market to Exhibit 17.2% CAGR and Reach USD 799.1 Million by 2026; Rise Remarkably on Account of Increasing Prevalence of Genetic Disorder...